(Q36584651)

15 August 2017

0 references

1 reference

title

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis (English)

1 reference

adaptive radiation therapy

15 August 2017

main subject

0 references

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

Jean-Pierre Pignon

20

0 references

Brian O'Sullivan

object named as

Brian O'Sullivan

11

0 references

Krzysztof Skladowski

14

object named as

Krzysztof Skladowski

1 reference

15 August 2017

4

Kian K Ang

1 reference

15 August 2017

Jean Bourhis

1

1 reference

15 August 2017

Jens Overgaard

2

1 reference

15 August 2017

Hélène Audry

3

1 reference

15 August 2017

Michele Saunders

5

1 reference

15 August 2017

Jacques Bernier

6

1 reference

15 August 2017

Jean-Claude Horiot

7

1 reference

15 August 2017

Aurélie Le Maître

8

1 reference

15 August 2017

Thomas F Pajak

9

1 reference

15 August 2017

Michael G Poulsen

10

1 reference

15 August 2017

Werner Dobrowsky

12

1 reference

15 August 2017

Andrzej Hliniak

13

1 reference

15 August 2017

John H Hay

15

1 reference

15 August 2017

Luiz H J Pinto

16

1 reference

15 August 2017

Carlo Fallai

17

1 reference

15 August 2017

Karen K Fu

18

1 reference

15 August 2017

Richard Sylvester

19

1 reference

15 August 2017

Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group

21

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

368

1 reference

15 August 2017

issue

9538

1 reference

15 August 2017

page(s)

843-854

1 reference

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

A note on quantifying follow-up in studies of failure time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969121-6

7 January 2021

10.1016/S0140-6736(06)69121-6

Identifiers

DOI

1 reference

15 August 2017

1 reference